| human | Q5 |
| P8446 | Gateway to Research person ID | 9370EB52-19BF-4601-A002-75DAA1BA1220 |
| P1960 | Google Scholar author ID | jGIMhpIAAAAJ |
| P269 | IdRef ID | 083941207 |
| P213 | ISNI | 0000000114401698 |
| P244 | Library of Congress authority ID | n2003130766 |
| P691 | NL CR AUT ID | nlk20050162488 |
| P856 | official website | https://medhealth.leeds.ac.uk/medhealth-admin/profile/523/881/david_l._buckley |
| P496 | ORCID iD | 0000-0001-6659-8365 |
| P3829 | Publons author ID | 1099529 |
| P1053 | ResearcherID | L-8343-2017 |
| P214 | VIAF ID | 26449087 |
| P10832 | WorldCat Entities ID | E39PBJj8Ww6WdxpRP647WgVt8C |
| P1416 | affiliation | Leeds Institute of Cardiovascular and Metabolic Medicine | Q26226452 |
| P185 | doctoral student | David Broadbent | Q47086448 |
| P108 | employer | University of Leeds | Q503424 |
| P734 | family name | Buckley | Q21484864 |
| Buckley | Q21484864 | ||
| Buckley | Q21484864 | ||
| P735 | given name | David | Q18057751 |
| David | Q18057751 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | researcher | Q1650915 |
| physician | Q39631 | ||
| P21 | sex or gender | male | Q6581097 |
| Q51682947 | A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas. |
| Q50234126 | A comparison of dual-bolus and dual-sequence quantitative myocardial perfusion techniques |
| Q44299287 | A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: application in carcinoma of the cervix |
| Q56587799 | Are Measurements from Two Commercial Software Packages Interchangeable? Possibly, If Like Is Compared with Like |
| Q50592850 | Assessment of bladder motion for clinical radiotherapy practice using cine-magnetic resonance imaging. |
| Q45891564 | Assessment of myocardial perfusion-CMR in left main stem disease (LMS) in the CEMARC study |
| Q45116563 | BOLD imaging: a potential predictive biomarker of renal functional outcome following revascularization in atheromatous renovascular disease. |
| Q56587484 | Benign prostatic hyperplasia: Evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI |
| Q40477780 | Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume. |
| Q33379841 | Cellular-interstitial water exchange and its effect on the determination of contrast agent concentration in vivo: dynamic contrast-enhanced MRI of human internal obturator muscle |
| Q30626277 | Classic models for dynamic contrast-enhanced MRI. |
| Q55471802 | Comparative study of methods for determining vascular permeability and blood volume in human gliomas. |
| Q46140795 | Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancer. |
| Q51158182 | Comparison of errors associated with single- and multi-bolus injection protocols in low-temporal-resolution dynamic contrast-enhanced tracer kinetic analysis. |
| Q51859499 | Comparison of normal tissue R1 and R*2 modulation by oxygen and carbogen. |
| Q43522285 | Computer three-dimensional anatomical reconstruction of the human sinus node and a novel paranodal area |
| Q56590247 | Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Breast Combined with Pharmacokinetic Analysis of Gadolinium-DTPA Uptake in the Diagnosis of Local Recurrence of Early Stage Breast Carcinoma |
| Q56589759 | Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours |
| Q52266562 | Dynamic MRI of invasive breast cancer: assessment of three region-of-interest analysis methods. |
| Q56590086 | Dynamic contrast enhanced MR |
| Q56590295 | Dynamic gradient-echo and fat-suppressed spin-echo contrast-enhanced MRI of the breast |
| Q56589673 | Effect of Temporal Resolution on the Diagnostic Efficacy of Contrast-Enhanced MRI in the Conservatively Treated Breast |
| Q56587215 | Effects of renal volume and single-kidney glomerular filtration rate on renal functional outcome in atherosclerotic renal artery stenosis |
| Q33620142 | Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix. |
| Q50710054 | Establishment of the National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad) Biomarker Support Network. |
| Q38859514 | Estimating breast tumor blood flow during neoadjuvant chemotherapy using interleaved high temporal and high spatial resolution MRI. |
| Q51120063 | Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. |
| Q35072208 | Functional, anatomical, and molecular investigation of the cardiac conduction system and arrhythmogenic atrioventricular ring tissue in the rat heart. |
| Q34974971 | Gadofosveset-based biomarker of tissue albumin concentration: Technical validation in vitro and feasibility in vivo |
| Q37420715 | Gadolinium-enhanced magnetic resonance imaging for renovascular disease and nephrogenic systemic fibrosis: critical review of the literature and UK experience |
| Q56589398 | Heterogeneity Analysis of Gd-DTPA Uptake: Improvement in Breast Lesion Differentiation |
| Q30242020 | Imaging biomarker roadmap for cancer studies |
| Q38007857 | Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. |
| Q36357607 | Imaging vascular physiology to monitor cancer treatment |
| Q48226455 | In vivo dynamics and distribution of intracerebroventricularly administered gadodiamide, visualized by magnetic resonance imaging |
| Q44488177 | In vivo prostate magnetic resonance imaging and magnetic resonance spectroscopy at 3 Tesla using a transceive pelvic phased array coil: preliminary results |
| Q55626115 | Investigation of the change in myocardial blood flow by perfusion CMR after revascularisation of chronically occluded coronary arteries. |
| Q33778192 | Kidney volume to GFR ratio predicts functional improvement after revascularization in atheromatous renal artery stenosis |
| Q47844587 | Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging |
| Q30667050 | MR microscopy of multicomponent diffusion in single neurons |
| Q32174793 | MR microscopy of perfused brain slices |
| Q47604435 | MR-derived renal morphology and renal function in patients with atherosclerotic renovascular disease |
| Q50665913 | Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group. |
| Q47590624 | Measurement of single kidney function using dynamic contrast-enhanced MRI: comparison of two models in human subjects |
| Q56589987 | Microvessel density in invasive breast cancer assessed by dynamic gd-dtpa enhanced MRI |
| Q51847616 | Modeling of contrast agent kinetics in the lung using T1-weighted dynamic contrast-enhanced MRI. |
| Q112576046 | Motion correction of free-breathing magnetic resonance renography using model-driven registration |
| Q45014010 | Multi-parametric MRI-guided focal tumor boost using HDR prostate brachytherapy: a feasibility study |
| Q51255475 | Myocardial blood flow at rest and stress measured with dynamic contrast-enhanced MRI: comparison of a distributed parameter model with a Fermi function model. |
| Q46265644 | On the scope and interpretation of the Tofts models for DCE-MRI. |
| Q50922182 | Organ-specific effects of oxygen and carbogen gas inhalation on tissue longitudinal relaxation times. |
| Q36882304 | Overcoming the low relaxivity of gadofosveset at high field with spin locking. |
| Q43608693 | Perfusion estimated with rapid dynamic contrast-enhanced magnetic resonance imaging correlates inversely with vascular endothelial growth factor expression and pimonidazole staining in head-and-neck cancer: a pilot study |
| Q51131040 | Precision in measurements of perfusion and microvascular permeability with T1-weighted dynamic contrast-enhanced MRI. |
| Q52841373 | Prediction and assessment of responses to renal artery revascularization with dynamic contrast-enhanced magnetic resonance imaging: a pilot study. |
| Q51701255 | Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. |
| Q47641673 | Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: a potential novel biomarker of oxygenation changes in solid tumors |
| Q51595562 | Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience. |
| Q52367881 | Quantitative analysis of multi-slice Gd-DTPA enhanced dynamic MR images using an automated simplex minimization procedure. |
| Q37232368 | Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives |
| Q48278209 | Renal Cell Carcinoma Perfusion before and after Radiofrequency Ablation Measured with Dynamic Contrast Enhanced MRI: A Pilot Study |
| Q40970917 | Sensitivity of quantitative myocardial dynamic contrast-enhanced MRI to saturation pulse efficiency, noise and t1 measurement error: Comparison of nonlinearity correction methods |
| Q51650425 | The effect of blood inflow and B(1)-field inhomogeneity on measurement of the arterial input function in axial 3D spoiled gradient echo dynamic contrast-enhanced MRI. |
| Q52841588 | The effects of cryoablation on renal cell carcinoma perfusion and glomerular filtration rate measured using dynamic contrast-enhanced MRI: a feasibility study. |
| Q33643193 | Tracer kinetic analysis of dynamic contrast-enhanced MRI and CT bladder cancer data: A preliminary comparison to assess the magnitude of water exchange effects |
| Q37968863 | Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability |
| Q56588897 | Transcytolemmal water exchange and its affect on the determination of contrast agent concentration in vivo |
| Q48875186 | Tumour volume determination from MR images by morphological segmentation |
| Q56589136 | Two-component diffusion tensor MRI of isolated perfused hearts |
| Q56588929 | Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhancedT1-weighted MRI |
| Q30644046 | Visualization of neural tissue water compartments using biexponential diffusion tensor MRI. |
| Q48094871 | What levels of precision are achievable for quantification of perfusion and capillary permeability surface area product using ASL? |
| Q47086448 | David Broadbent | doctoral advisor | P184 |
Search more.